BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 34979454)

  • 1. Enrichment and MALDI-TOF MS Analysis of Phosphoinositides in Brain Tissue.
    Le HT; Nguyen DPL; Jung GT; Kim E; Yang SH; Lee SM; Lee EA; Jung W; Kim TW; Kim KP
    J Am Soc Mass Spectrom; 2024 Apr; ():. PubMed ID: 38603805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies.
    Khademi R; Mohammadi Z; Khademi R; Saghazadeh A; Rezaei N
    Nanoscale Adv; 2023 Jan; 5(3):571-595. PubMed ID: 36756502
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced-Precision Measurement of Glutathionyl Hemoglobin by MALDI-ToF MS.
    Rubino FM; Ottolenghi S; Brizzolari A; Maioli C; Samaja M; Paroni R
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilized fusion protein affinity chromatography combined with HPLC-ESI-Q-TOF-MS/MS for rapid screening of PPARγ ligands from natural products.
    Zhu J; Yi X; Liu W; Xu Y; Chen S; Wu Y
    Talanta; 2017 Apr; 165():508-515. PubMed ID: 28153290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of MALDI-TOF-MS and HPLC-ESI-MS/MS for endopeptidase activity-based quantification of Anthrax lethal factor in serum.
    Kuklenyik Z; Boyer AE; Lins R; Quinn CP; Gallegos-Candela M; Woolfitt A; Pirkle JL; Barr JR
    Anal Chem; 2011 Mar; 83(5):1760-5. PubMed ID: 21302970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of glycation and glycation sites of lysozyme by matrix-assisted laser desorption/ionization time of flight/time-of-flight mass spectrometry and Liquid chromatography-electrospray ionization tandem mass spectrometry.
    Ruan ED; Wang H; Ruan Y; Juáreza M
    Eur J Mass Spectrom (Chichester); 2014; 20(4):327-36. PubMed ID: 25420345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of MS/MS-based, stable-isotope-labeled, quantitation performance on ESI-quadrupole TOF and MALDI-TOF/TOF mass spectrometers.
    Kuzyk MA; Ohlund LB; Elliott MH; Smith D; Qian H; Delaney A; Hunter CL; Borchers CH
    Proteomics; 2009 Jun; 9(12):3328-40. PubMed ID: 19504495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyphenated LC-MALDI-ToF/ToF and LC-ESI-QToF approach in proteomic characterization of honeybee venom.
    Matysiak J; Hajduk J; Mayer F; Hebeler R; Kokot ZJ
    J Pharm Biomed Anal; 2016 Mar; 121():69-76. PubMed ID: 26780156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Spectrometry: A Powerful Method for Monitoring Various Type of Leukemia, Especially MALDI-TOF in Leukemia's Proteomics Studies Review.
    Fasih Ramandi N; Faranoush M; Ghassempour A; Aboul-Enein HY
    Crit Rev Anal Chem; 2022; 52(6):1259-1286. PubMed ID: 33499652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of Glutathione S-transferase-P1 in cancer blood plasma after extraction by affinity magnetic nanoparticles and monitoring by MALDI-TOF, IM-Q-TOF and LC-ESI-Q-TOF MS.
    Fasih Ramandi N; Soleimani Mashhadi I; Sharif A; Saeedi N; Ashabi MA; Faranoush M; Ghassempour A; Aboul-Enein HY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Feb; 1190():123091. PubMed ID: 34979454
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.